1. Home
  2. AVBP vs CSV Comparison

AVBP vs CSV Comparison

Compare AVBP & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • CSV
  • Stock Information
  • Founded
  • AVBP 2021
  • CSV 1991
  • Country
  • AVBP United States
  • CSV United States
  • Employees
  • AVBP N/A
  • CSV N/A
  • Industry
  • AVBP
  • CSV Other Consumer Services
  • Sector
  • AVBP
  • CSV Consumer Discretionary
  • Exchange
  • AVBP NYSE
  • CSV Nasdaq
  • Market Cap
  • AVBP 705.8M
  • CSV 634.3M
  • IPO Year
  • AVBP 2024
  • CSV 1996
  • Fundamental
  • Price
  • AVBP $25.22
  • CSV $43.77
  • Analyst Decision
  • AVBP Strong Buy
  • CSV Strong Buy
  • Analyst Count
  • AVBP 7
  • CSV 2
  • Target Price
  • AVBP $39.29
  • CSV $50.50
  • AVG Volume (30 Days)
  • AVBP 377.5K
  • CSV 82.7K
  • Earning Date
  • AVBP 08-13-2025
  • CSV 07-30-2025
  • Dividend Yield
  • AVBP N/A
  • CSV 1.03%
  • EPS Growth
  • AVBP N/A
  • CSV 47.76
  • EPS
  • AVBP N/A
  • CSV 2.99
  • Revenue
  • AVBP N/A
  • CSV $407,774,000.00
  • Revenue This Year
  • AVBP $66.25
  • CSV $1.96
  • Revenue Next Year
  • AVBP N/A
  • CSV $2.93
  • P/E Ratio
  • AVBP N/A
  • CSV $14.67
  • Revenue Growth
  • AVBP N/A
  • CSV 4.42
  • 52 Week Low
  • AVBP $15.47
  • CSV $25.84
  • 52 Week High
  • AVBP $36.37
  • CSV $46.15
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 67.19
  • CSV 52.41
  • Support Level
  • AVBP $22.65
  • CSV $43.15
  • Resistance Level
  • AVBP $25.80
  • CSV $46.15
  • Average True Range (ATR)
  • AVBP 1.32
  • CSV 0.92
  • MACD
  • AVBP 0.18
  • CSV -0.22
  • Stochastic Oscillator
  • AVBP 87.89
  • CSV 23.96

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: